Global pharmaceutical companies are flexible with corporate merger and business acquisition. They are not afraid to take a better choice to survive and advance forward in ever-changing trend.

Although such drastic changes cause restructure, downsizing and other issues, global companies have constantly taken the path of changes so far.

A dermatology specialist company, Galderma also has just gone through a dramatic change. As of Oct. 2, Galderma closed a 12-trillion-won (about CHF 10.2 billion) deal with Nestlé Skin Health to take over its sole ownership. Since then Galderma has transformed into an independent global dermatology company after separating from the old owner company